Centerpulse Divestiture Plan Complete With Sale Of Heart Valve Biz To Snia
This article was originally published in The Gray Sheet
Executive Summary
Centerpulse's exit from the cardiovascular market is complete with the Nov. 27 sale of its Carbomedics and Mitroflow mechanical and tissue heart valve units to Milan-based Snia
You may also be interested in...
S&N’s $2.3 Bil. Centerpulse Merger Adds Largest European Orthopedic Player
The acquisition of Centerpulse for $2.3 bil. will allow Smith & Nephew to leapfrog Johnson & Johnson/DePuy and Stryker to become the largest manufacturer of orthopedic implants outside the U.S
S&N’s $2.3 Bil. Centerpulse Merger Adds Largest European Orthopedic Player
The acquisition of Centerpulse for $2.3 bil. will allow Smith & Nephew to leapfrog Johnson & Johnson/DePuy and Stryker to become the largest manufacturer of orthopedic implants outside the U.S
Terumo’s $170 Mil. Vascutek Purchase Builds Cardiovascular Offerings
Terumo Medical's annual sales will approach $230 mil. through the purchase of Centerpulse's Vascutek vascular graft division. A definitive purchase agreement was announced Oct. 4